Biodesix, Inc.BDSXNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank57
5Y CAGR-22.4%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

5Y CAGR
-22.4%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202524.08%
202445.30%
202328.46%
2022-29.89%
202119.64%
202085.55%
201920.16%
20180.00%